Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors

Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors

US Patent 9951118 · Granted Apr 24, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vault particles having a modified R8 flexible region2023
Methods for selectively expanding and enriching cells transduced with chimeric a2021
Methods for selectively expanding and enriching cells transduced with chimeric a2021
Methods for selectively expanding and enriching cells transduced with chimeric a2021
Methods for selectively expanding and enriching cells transduced with chimeric a2021
Method for expression of small antiviral RNA molecules with reduced cytotoxicity2020
HIV peptide vaults and methods of making and using thereof2020
RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules2020
RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules2020
Viral vector nanocapsule for targeting gene therapy and its preparation2019
Method for expression of small antiviral RNA molecules with reduced cytotoxicity2018
RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules2017